Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0001193125-26-031826

Options or other derivatives

  • Chief Financial Officer acquired 422,298 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Wilterding Mark Chief Financial Officer 2026-01-12 Grant or award · Stock Option (right to buy) +258,770 258,770 D
Wilterding Mark Chief Financial Officer 2026-01-12 Grant or award · Restricted Stock Unit +163,528 163,528 D
Loading xslF345X05/ownership.xml…